Neuraptive Therapeutics Licenses Innovative Bioresorbable Nerve Stimulation Technology from Washington University in St. Louis

Business Wire India Neuraptive Therapeutics, Inc., a clinical-stage biotech company focused on peripheral nerve injuries, announced today that it has secured an exclusive license from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device.   Developed by researchers at WashU Medicine in collaboration with Northwestern University, the technology delivers targeted electrical pulses to damaged nerves to speed up regeneration. The device is…

Cover Genius Raises USD $100M Backed by Vista Credit Partners, Reaching USD $1.9 Billion Valuation as it Advances AI-First Platform and Global Expansion

Business Wire India Cover Genius, the global infrastructure for embedded protection, today announced a USD $100M capital raise, backed by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on enterprise software. The raise values the business at USD $1.9 billion, advancing a new chapter for the company.   Cover Genius operates a B2B2C embedded protection platform that connects 200+…

STARTEEPO Increases Xerox Position to 8.8 Million Shares, Becomes Second-Largest Common Shareholder

Business Wire India STARTEEPO Invest (“STARTEEPO”), a Prague-based alternative investment fund focused on high-conviction public equity investments, today announced that it has increased its beneficial ownership position in Xerox Holdings Corporation (“Xerox” or the “Company”) to 8.8 million common shares, together with options on an additional 140,000 shares, as disclosed in an amended Schedule 13D filing with the U.S. Securities and Exchange Commission.   Based…

European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation

Business Wire India   ERBITUX in combination with encorafenib and FOLFOX is the first and only approved targeted regimen for the first-line treatment of adult patients with BRAF V600E-mutant mCRC The approval is based on the pivotal Phase 3 BREAKWATER trial, which demonstrated statistically significant and clinically meaningful improvements in both progression-free survival (PFS) and overall survival (OS) compared to standard chemotherapy with or without…

Omdia: Global Smartphone Market Down 4% in 2Q26 While Apple and Samsung Soared

Business Wire India   According to Omdia’s latest research, global smartphone shipments fell 4% year-on-year in 2Q26 as the ongoing memory crisis disrupted supply and pushed up component costs. The current dynamic has created severe market polarization, reflecting stark differences in vendors’ mitigation strategies which vary according to their priorities, scale, price-band focus, and core audience demographics.   This press release features multimedia. View the…

Esri Introduces ArcGIS Velocity for ArcGIS Enterprise to Power Real-Time GIS Operations

Business Wire India   ArcGIS Velocity Brings Real-Time Data Ingestion, Analysis, and Automated Alerting to ArcGIS Enterprise Deployments   Esri announces that ArcGIS Velocity is now available for ArcGIS Enterprise, enabling real-time data analytics and automated actions in self-hosted environments. This capability’s new deployment unifies real-time workflows across ArcGIS Online and ArcGIS Enterprise. This update benefits organizations across industries: public safety, transportation, logistics, and more.…

HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform

Business Wire India HistoSonics, today announced that the company has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histotripsy technology in Europe and other markets that recognize the CE Mark.   This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713505048/en/     HistoSonics Edison® Histotripsy System   The Edison System is a novel, non-invasive, image…

SLB OneSubsea Awarded EPC Contract for Eni’s Baleine Phase 3 Project Offshore Côte d’Ivoire

Business Wire India Global energy technology company SLB (NYSE: SLB) announced today that its OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire.   This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712734539/en/     SLB OneSubsea™ joint venture has been awarded a major…

Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation

Business Wire India Over 10,000 entries from 177 countries mark the highest participation in the Prize’s history Submissions increased 32% year-on-year, reflecting sustained local led momentum for scalable global impact Through 139 winners, the Prize has positively impacted more than 411 million lives worldwide   The Zayed Sustainability Prize, the UAE’s pioneering award for innovative solutions to global challenges, has officially closed submissions for its…

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer

Business Wire India $85M upfront financing, along with up to $255 million upon exercise of purchase warrants, is expected to fund ROBBIN1, Agenus’ registrational Phase 3 trial of neoadjuvant botensilimab and balstilimab (BOT+BAL) in microsatellite-stable (MSS) colon cancer Transaction is structured to fund Agenus through key value-inflection points, including interim topline pathologic response data and interim and final event-free survival (EFS) analyses, with proceeds to…